Exaggerated IL-17A activity in human in vivo recall responses discriminates active tuberculosis from latent infection and cured disease
Gabriele Pollara, Carolin T. Turner, Joshua Rosenheim, Aneesh Chandran, Lucy Bell, Ayesha Khan, Amit A. Patel, Luis Felipe Peralta, et al. (20 authors)
Science Translational Medicine · 2021-05
Abstract
17 differentiation within tissues. Modulation of these cytokine pathways may provide a rational strategy for host-directed therapy in active TB.
MeSH terms
- Latent tuberculosis
- In vivo
- Active tuberculosis
- Immunology
- Tuberculosis
- Medicine
- Disease
- Mycobacterium tuberculosis
- Immunopathology
- Ex vivo